1,048 results on '"Khan, Muhammad Shahzeb"'
Search Results
2. Global epidemiology of heart failure
3. Cardiac wasting in patients with cancer
4. Selective aldose reductase inhibition as a treatment for diabetic cardiomyopathy: summary of the ARISE-HF trial
5. GLP-1 Receptor Agonists and Cardiovascular Disease: What Do Clinicians Need to Know?
6. Estimated Glomerular Filtration Rate Slope as an Endpoint in Cardiovascular Trials
7. Chitosan-Based Adsorbents and Catalysts for Removal of Toxic Pollutants from Water and Wastewater
8. Prognostic value of quality of life and functional status in patients with heart failure: a systematic review and meta-analysis
9. Kidney and cardiovascular-protective benefits of combination drug therapies in chronic kidney disease associated with type 2 diabetes
10. Nanomaterials for the Catalytic Degradation and Detection of Microplastics: A Review
11. Acetazolamide as an Adjunctive Diuretic Therapy for Patients with Acute Decompensated Heart Failure: A Systematic Review and Meta-Analysis
12. Antero-lateral vs. antero-posterior electrode position for cardioversion of atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials
13. Vericiguat and Cardiovascular Outcomes in Heart Failure by Baseline Diabetes Status: Insights From the VICTORIA Trial
14. From Hospital to Home: Evidence-Based Care for Worsening Heart Failure
15. Interleukin-6 and Cardiovascular Events in Healthy Adults: MESA
16. Eligibility and Projected Benefits of Rapid Initiation of Quadruple Therapy for Newly Diagnosed Heart Failure
17. Trends in cancer and heart failure related mortality in adult US population: A CDC WONDER database analysis from 1999 to 2020
18. Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis
19. Nano-based remediation strategies for micro and nanoplastic pollution
20. Prevalence and Predictors of Readmissions in Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation/Flutter
21. Patterns, Prognostic Implications, and Rural-Urban Disparities in Optimal GDMT Following HFrEF Diagnosis Among Medicare Beneficiaries
22. A Phenomapping Tool and Clinical Score to Identify Low Diuretic Efficiency in Acute Decompensated Heart Failure
23. Pharmacotherapies in Heart Failure With Preserved Ejection Fraction: A Systematic Review and Network Meta-Analysis
24. Closing the Last Mile Gap in Access to Multimodality Imaging in Rural Settings: Design of the Imaging Core of the Risk Underlying Rural Areas Longitudinal Study
25. Natriuretic Peptides and Prognosis in Patients With Type 2 Diabetes Mellitus and High Risk for Cardiovascular Events
26. Bridging gaps and optimizing implementation of guideline-directed medical therapy for heart failure
27. The spectrum of post-myocardial infarction care: From acute ischemia to heart failure
28. Polypharmacy and Optimization of Guideline-Directed Medical Therapy in Heart Failure: The GUIDE-IT Trial
29. Frailty and Its Implications in Heart Failure with Reduced Ejection Fraction: Impact on Prognosis and Treatment
30. Optimal Screening for Predicting and Preventing the Risk of Heart Failure Among Adults With Diabetes Without Atherosclerotic Cardiovascular Disease: A Pooled Cohort Analysis
31. Vascular Disease Burden, Outcomes and Benefits with Empagliflozin in Heart Failure: Insights From the EMPEROR-Reduced Trial
32. Comparison of 30-day Readmission Rates and Inpatient Cardiac Procedures for Weekday Versus Weekend Hospital Admissions for Heart Failure
33. Association of Chronic Renal Insufficiency with Inhospital Outcomes in Primary Heart Failure Hospitalizations (Insights from the National Inpatient Sample 2004 to 2018)
34. Implementing Guideline-Directed Medical Therapy for Heart Failure: JACC Focus Seminar 1/3
35. Association of Non-Alcoholic Fatty Liver Disease With in-Hospital Outcomes in Primary Heart Failure Hospitalizations With Reduced or Preserved Ejection Fraction
36. An Individual Patient-Level Meta-Analysis of Ischemic Versus Nonischemic Cardiomyopathy and Trajectory of Decongestion in Patients With Acute Decompensated Heart Failure
37. Predicting and preventing heart failure in type 2 diabetes
38. Utilization Rates of SGLT2 Inhibitors Among Patients With Type 2 Diabetes, Heart Failure, and Atherosclerotic Cardiovascular Disease: Insights From the Department of Veterans Affairs
39. Safety and feasibility of same-day discharge for catheter ablation of atrial fibrillation: a systematic review and meta-analysis
40. The need for increased pragmatism in cardiovascular clinical trials
41. In Silico modeling and exploration of new acceptor molecules with enhanced power conversion efficiency for high-performance organic solar cell applications
42. Effect of Canagliflozin on Heart Failure Hospitalization in Diabetes According to Baseline Heart Failure Risk
43. Demographic and Regional Trends of Cardiovascular Diseases and Diabetes Mellitus-Related Mortality in the United States From 1999 to 2019
44. Effect of SGLT2 Inhibitors on Cardiovascular Outcomes Across Various Patient Populations
45. Minimal Clinically Important Differences in 6-Minute Walk Test in Patients With HFrEF and Iron Deficiency
46. Ejection Fraction, Biomarkers, and Outcomes and Impact of Vericiguat on Outcomes Across EF in VICTORIA
47. Management of Heart Failure With Reduced Ejection Fraction in Patients With Diabetes Mellitus and Chronic Kidney Disease
48. Inconsistent Outcome Reporting in Heart Failure Randomized Controlled Trials
49. Medication-Attributable Adverse Events in Heart Failure Trials
50. Combustion and emission characterization of upgraded biomass fast pyrolysis oil in a swirl burner
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.